17-alpha-hydroxyprogesterone has been researched along with ganirelix in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, AB; Evans, WS; Gingrich, MB; Hu, Y; Marshall, JC; McCartney, CR; Veldhuis, JD | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and ganirelix
Article | Year |
---|---|
Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Body Mass Index; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infusions, Intravenous; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pulse Therapy, Drug; Receptors, LHRH; Recombinant Proteins | 2004 |